A trader at work after the Nasdaq’s opening ceremony on April 18, 2019 in New York City.
Got Betancur | Getty images
Check out the companies making headlines after the bell on Monday:
Video Zoom – Shares of the video communications company declined 8.5% on better-than-expected fourth-quarter fiscal results. Zoom made $ 1.22 per share on sales of $ 882 million. Analysts polled by Refinitiv expected earnings of 79 cents a share on revenue of $ 812 million. That sales figure represents an increase of 369% year-on-year. Zoom also expects revenue to grow 175% in the fiscal first quarter and 42% for the full fiscal year.
Roku – Roku’s stock rose 2.8% on news that the company will acquire Nielsen’s video ad business. “By combining Nielsen’s AVA technology with Roku’s innovative advertising technology and scale, we can deliver the benefits of TV streaming ads on traditional TV,” Louqman Parampath, Roku’s vice president of product management, said in a statement.
Novavax – The vaccine developer’s share fell 4.2% after the company reported weaker-than-expected fourth-quarter results. Novavax lost $ 2.70 per share on sales of $ 279.7 million. Analysts polled by Refinitv expected a loss per share of $ 1.49 on revenue of $ 304.9 million. CEO Stanley Erck told CNBC the company is expecting government approval for its Covid-19 vaccine as early as May.
Inovio Pharmaceuticals – Inovio shares were down more than 6% after the company released its latest quarterly results. The company lost 14 cents a share, while analysts polled by FactSet expected a loss of 22 cents a share. In addition, Inovio published Phase 3 trial results for a drug targeting HPV treatment.